MDWD MediWound Ltd. Stock Quote

MDWD [NASD]

Index	-	P/E	-	EPS (ttm)	-0.34	Insider Own	42.96%	Shs Outstand	27.22M	Perf Week	-4.85%
Market Cap	141.78M	Forward P/E	-	EPS next Y	-0.54	Insider Trans	0.00%	Shs Float	15.57M	Perf Month	-9.25%
Income	-9.30M	PEG	-	EPS next Q	-0.11	Inst Own	19.50%	Short Float	0.52%	Perf Quarter	29.77%
Sales	21.80M	P/S	6.50	EPS this Y	-548.40%	Inst Trans	4.29%	Short Ratio	0.51	Perf Half Y	36.36%
Book/sh	0.27	P/B	18.89	EPS next Y	-125.00%	ROA	-26.50%	Target Price	7.67	Perf Year	209.09%
Cash/sh	0.77	P/C	6.63	EPS next 5Y	-	ROE	-94.50%	52W Range	1.61 - 6.07	Perf YTD	37.84%
Dividend	-	P/FCF	-	EPS past 5Y	19.30%	ROI	-92.10%	52W High	-15.98%	Beta	1.58
Dividend %	-	Quick Ratio	3.00	Sales past 5Y	105.00%	Gross Margin	34.70%	52W Low	216.77%	ATR	0.37
Employees	75	Current Ratio	3.20	Sales Q/Q	24.10%	Oper. Margin	-40.90%	RSI (14)	46.19	Volatility	4.82% 6.78%
Optionable	No	Debt/Eq	0.32	EPS Q/Q	51.00%	Profit Margin	-42.30%	Rel Volume	0.52	Prev Close	5.26
Shortable	Yes	LT Debt/Eq	0.23	Earnings	Feb 25 BMO	Payout	-	Avg Volume	158.29K	Price	5.10
Recom	1.70	SMA20	-3.66%	SMA50	-5.36%	SMA200	22.16%	Volume	85,208	Change	-3.04%

Sep-23-20

Initiated

BTIG Research

Buy

Nov-28-16

Initiated

Aegis Capital

Buy

$11

Aug-17-16

Initiated

Wells Fargo

Outperform

Apr-16-14

Initiated

Oppenheimer

Outperform

$25

Apr-02-21 03:54AM	Companies Like MediWound (NASDAQ:MDWD) Are In A Position To Invest In Growth Simply Wall St.
Mar-24-21 04:05PM	MediWound Hosting Analyst Day Webinar on EscharEx Enzymatic Debridement Agent for Chronic Wounds GlobeNewswire -7.06%
Feb-25-21 04:01PM	MediWound to Participate in Upcoming March Investment Conferences GlobeNewswire -5.54%
07:00AM	MediWound Reports Fourth Quarter and Full-Year 2020 Financial Results GlobeNewswire
06:30AM	MediWound Ltd. to Host Earnings Call ACCESSWIRE
Feb-22-21 06:30AM	MediWound Launches Clinical Development Program for Treatment of Non-Melanoma Skin Cancer GlobeNewswire -9.63%
Feb-16-21 04:05PM	MediWound to Report Fourth Quarter and Fiscal 2020 Financial Results and Host a Conference Call and Webcast on February 25, 2021 GlobeNewswire +6.65%
Feb-10-21 04:15PM	MediWound to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference GlobeNewswire
Feb-01-21 04:02AM	MediWound (NASDAQ:MDWD) Shareholders Have Enjoyed A 59% Share Price Gain Simply Wall St.
Jan-11-21 07:00AM	MediWound Provides Progress Update on Its EscharEx Clinical Development Program GlobeNewswire
Jan-05-21 07:00AM	MediWound to Participate in Upcoming Investor Conferences in January GlobeNewswire +5.84%
Dec-21-20 07:30AM	Successful Completion of In-Vivo Head-to-Head Comparator Study of EscharEx versus a Commercial Enzymatic Debridement Agent GlobeNewswire
Dec-15-20 07:52AM	The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga
Dec-14-20 04:15PM	MediWound Continues Global Expansion with Distribution Agreement for NexoBrid in United Arab Emirates with Ghassan Aboud Group GlobeNewswire
Nov-30-20 02:18AM	Is MediWound Ltd.'s (NASDAQ:MDWD) Shareholder Ownership Skewed Towards Insiders? Simply Wall St.
Nov-10-20 08:45AM	MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:33AM	MediWound: Q3 Earnings Insights Benzinga
07:00AM	MediWound Reports Third Quarter 2020 Financial Results GlobeNewswire
Nov-03-20 12:30PM	Will MediWound (MDWD) Report Negative Earnings Next Week? What You Should Know Zacks
Nov-02-20 04:01PM	MediWound to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 10, 2020 GlobeNewswire +8.97%
Oct-28-20 07:00AM	MediWound Completes Enrollment Stage of its NexoBrid Phase 3 Pediatric Study GlobeNewswire
Oct-14-20 08:00AM	MediWound Studying the Effect of EscharEx on Biofilm Burden GlobeNewswire
Sep-29-20 10:17AM	We're Not Very Worried About MediWound's (NASDAQ:MDWD) Cash Burn Rate Simply Wall St.
Sep-16-20 07:30AM	MediWound Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns GlobeNewswire
Sep-15-20 12:14PM	Oppenheimer: 3 Stocks That Could Surge Over 100% From Current Levels TipRanks +15.53%
Sep-03-20 09:00AM	MediWound to Present at Upcoming Investor Conferences in September GlobeNewswire
Aug-25-20 07:00AM	MediWound and Vericel Announce Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response Preparedness GlobeNewswire +26.54%
Aug-06-20 12:35PM	MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates Zacks
07:00AM	MediWound Reports Second Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
Jul-31-20 02:53PM	Should MediWound (NASDAQ:MDWD) Be Disappointed With Their 52% Profit? Simply Wall St.
Jul-30-20 12:33PM	MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-28-20 08:00AM	MediWound to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020 GlobeNewswire
Jul-14-20 08:54AM	MediWound (MDWD) Jumps: Stock Rises 9.4% Zacks
Jun-30-20 07:00AM	MediWound Announces Submission of Biologics License Application to the U.S. FDA for NexoBrid for the Treatment of Severe Thermal Burns GlobeNewswire +11.24%
May-27-20 10:29AM	Zacks.com featured highlights include: MediWound, Issuer Direct, BWX Technologies and Teekay Tankers Zacks
May-26-20 08:16AM	4 Profitable Stocks to Boost Returns Using Net Income Ratio Zacks
May-20-20 08:15AM	MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:13AM	Recap: MediWound Q1 Earnings Benzinga
07:00AM	MediWound Reports First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
06:30AM	MediWound Ltd. to Host Earnings Call ACCESSWIRE
May-13-20 08:00AM	MediWound to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on May 20, 2020 GlobeNewswire -9.00%
May-12-20 12:30PM	MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
May-04-20 07:30AM	MediWound Strengthens its NexoBrid European Presence with Additional Distribution Agreements GlobeNewswire
May-02-20 10:18AM	MediWound Ltd.'s (NASDAQ:MDWD) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? Simply Wall St.
Apr-27-20 07:00AM	MediWound Strengthens Board of Directors GlobeNewswire
Mar-30-20 07:30AM	MediWound Provides Corporate Update Related to COVID-19 Pandemic GlobeNewswire
Mar-10-20 03:17AM	Edited Transcript of MDWD earnings conference call or presentation 25-Feb-20 1:30pm GMT Thomson Reuters StreetEvents +8.97%
Mar-03-20 06:00AM	BARDA Upsizes its Contract with MediWound Awarding an Additional $5.5 Million for Emergency Readiness for NexoBrid Deployment GlobeNewswire
Feb-28-20 04:18PM	MediWound to Present at Cowen and Company 40th Annual Healthcare Conference GlobeNewswire +16.39%
Feb-25-20 08:45AM	MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates Zacks -7.53%
07:00AM	MediWound Reports Fourth Quarter and Full-Year 2019 Financial Results GlobeNewswire
06:30AM	MediWound Ltd. to Host Earnings Call ACCESSWIRE
Feb-18-20 08:00AM	MediWound to Report Fourth Quarter & Fiscal 2019 Financial Results and Host a Conference Call and Webcast on February 25, 2020 GlobeNewswire
Jan-13-20 08:00AM	MediWound Expands its Distribution Agreement with GENFA MEDICA SA to Market NexoBrid in Ukraine and the Baltic States GlobeNewswire
Jan-06-20 06:30AM	BARDA Initiates the Procurement of NexoBrid for Emergency Response GlobeNewswire
Jan-03-20 11:29AM	If You Had Bought MediWound (NASDAQ:MDWD) Stock Five Years Ago, You'd Be Sitting On A 57% Loss, Today Simply Wall St.
Jan-02-20 07:30AM	MediWound Continues NexoBrids Global Expansion Through a New Distribution Agreement in Australia, New Zealand and Singapore with Balance Medical GlobeNewswire
Dec-06-19 12:00AM	Edited Transcript of MDWD earnings conference call or presentation 14-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Dec-03-19 07:30AM	MediWound Initiates U.S. Phase 2 Adaptive Design Study of EscharEx® for Treatment of Venous Leg Ulcers GlobeNewswire
Nov-14-19 08:25AM	MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates Zacks +7.72%
07:00AM	MediWound Reports Third Quarter 2019 Financial Results GlobeNewswire
Nov-07-19 10:30AM	Earnings Preview: MediWound (MDWD) Q3 Earnings Expected to Decline Zacks
Nov-06-19 08:00AM	MediWound to Report Third Quarter 2019 Financial Results and Host a Conference Call and Webcast on November 14 GlobeNewswire
Nov-05-19 10:31AM	Analysts Estimate MediWound (MDWD) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-02-19 07:30AM	Vericel and MediWound Announce Initiation of U.S. NexoBrid Expanded Access Treatment Protocol GlobeNewswire
Sep-03-19 08:00AM	NexoBrid® Highlighted in 39 Presentations at the 18th European Burns Association Congress in Helsinki GlobeNewswire
Aug-21-19 03:14PM	Edited Transcript of MDWD earnings conference call or presentation 13-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-14-19 07:02AM	Could MediWound Ltd.'s (NASDAQ:MDWD) Investor Composition Influence The Stock Price? Simply Wall St. -5.05%
Aug-13-19 08:35AM	MediWound (MDWD) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:00AM	MediWound Reports Second Quarter 2019 Financial Results GlobeNewswire
06:30AM	MediWound Ltd. to Host Earnings Call ACCESSWIRE
Aug-06-19 08:00AM	MediWound to Report Second Quarter 2019 Financial Results and Host a Conference Call and Webcast on August 13 GlobeNewswire
Jul-30-19 10:38AM	Will MediWound (MDWD) Report Negative Q2 Earnings? What You Should Know Zacks -8.26%
Jul-22-19 07:00AM	MediWound Launches EscharEx® U.S. Clinical Development Program GlobeNewswire
Jul-16-19 08:00AM	MediWound to Host Analyst Day on its Innovative Product EscharEx® for Debridement of Chronic Wounds GlobeNewswire
Jun-21-19 12:53PM	Does The MediWound Ltd. (NASDAQ:MDWD) Share Price Tend To Follow The Market? Simply Wall St. -15.73%
12:50PM	How Does MediWound Ltd. (NASDAQ:MDWD) Affect Your Portfolio Volatility? Simply Wall St.
Jun-12-19 11:02PM	Edited Transcript of MDWD earnings conference call or presentation 21-May-19 12:30pm GMT Thomson Reuters StreetEvents
Jun-11-19 07:30AM	MediWound Appoints Mr. Boaz Gur-Lavie as Chief Financial Officer GlobeNewswire -6.70%
Jun-04-19 07:30AM	NexoBrid® Receives Marketing Authorization from Perus Ministry of Health GlobeNewswire
May-29-19 07:30AM	BARDA Upsizes Support for NexoBrid with an Additional $21 Million to Fund Continuous Access Treatment Protocol for Thermal Burn GlobeNewswire
May-21-19 08:25AM	MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:15AM	MediWound: 1Q Earnings Snapshot Associated Press
07:00AM	MediWound Reports First Quarter 2019 Financial Results GlobeNewswire
May-14-19 08:00AM	MediWound to Host First Quarter Financial Results Conference Call on May 21at 8:30 a.m. Eastern Time GlobeNewswire
May-08-19 06:24AM	Vericel (VCEL) Q1 2019 Earnings Call Transcript Motley Fool
May-07-19 02:00AM	MediWound Enters into Exclusive License Agreement with Vericel for Commercial Rights to NexoBrid® in North America GlobeNewswire -10.67%
May-02-19 10:33AM	Will MediWound (MDWD) Report Negative Q1 Earnings? What You Should Know Zacks -5.18%
Mar-28-19 12:23PM	Edited Transcript of MDWD earnings conference call or presentation 25-Mar-19 12:30pm GMT Thomson Reuters StreetEvents
Mar-26-19 08:00AM	MediWound Files Annual Report on Form 20-F for the Year Ended December 31, 2018 GlobeNewswire
Mar-25-19 07:26AM	MediWound: 4Q Earnings Snapshot Associated Press
07:00AM	MediWound Reports Fourth Quarter and Fiscal Year 2018 Financial Results GlobeNewswire
Mar-18-19 08:00AM	MediWound to Host Fourth Quarter & Fiscal 2018 Financial Results Conference Call on March 25 at 8:30 a.m. Eastern Time GlobeNewswire
Mar-12-19 07:00AM	MediWound Announces Executive Leadership Changes GlobeNewswire
Mar-11-19 10:30AM	Earnings Preview: MediWound (MDWD) Q4 Earnings Expected to Decline Zacks
Feb-12-19 01:40PM	Do Institutions Own MediWound Ltd. (NASDAQ:MDWD) Shares? Simply Wall St.
Jan-22-19 09:25AM	4 Healthcare Stocks Looking to Set the Pace on Tuesday (1/22/19) ACCESSWIRE +11.64%
06:30AM	MediWound Announces Positive Top-Line Results from Its Pivotal Phase 3 Study (DETECT) in NexoBrid® for Eschar Removal of Severe Thermal Burns GlobeNewswire
Jan-07-19 07:00AM	MediWounds Late Stage Clinical Products Review, Analysts Review and Target ACCESSWIRE
Dec-19-18 04:38PM	Edited Transcript of MDWD earnings conference call or presentation 13-Nov-18 1:30pm GMT Thomson Reuters StreetEvents

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience